| scholarly article | Q13442814 |
| P2093 | author name string | Mohammed Faraj Al-Marjani | |
| Mustafa Kahtan Al-Bayaty | |||
| Salma Abdul-Rudha Abass | |||
| P2860 | cites work | A core function for p120-catenin in cadherin turnover | Q24672238 |
| Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis | Q26775839 | ||
| Diagnosis of Helicobacter pylori infection: Current options and developments | Q26777558 | ||
| E-cadherin and gastric cancer: cause, consequence, and applications | Q27000278 | ||
| Levels of soluble E-cadherin in breast, gastric, and colorectal cancers | Q27012638 | ||
| Convergence of Wnt, beta-catenin, and cadherin pathways | Q29619504 | ||
| PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer | Q33935399 | ||
| Helicobacter pylori infection - recent developments in diagnosis | Q33948313 | ||
| Helicobacter pylori and gastric cancer: factors that modulate disease risk | Q34189885 | ||
| Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. | Q34542021 | ||
| The clinical significance of elevated levels of serum CA 19-9. | Q34548548 | ||
| Preoperative serum tumor marker levels in gastric cancer | Q34660420 | ||
| Diagnosis of Helicobacter pylori: what should be the gold standard? | Q35297763 | ||
| Soluble E-cadherin is a valid prognostic marker in gastric carcinoma | Q35363994 | ||
| Soluble E-cadherin fragments increased in circulation of cancer patients | Q35978360 | ||
| Characterization of soluble E-cadherin as a disease marker in gastric cancer patients | Q36115556 | ||
| Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer | Q36431542 | ||
| United Rapid Urease Test Is Superior than Separate Test in Detecting Helicobacter pylori at the Gastric Antrum and Body Specimens | Q36465765 | ||
| Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer | Q36640236 | ||
| Serum biomarker panels for diagnosis of gastric cancer | Q36858170 | ||
| Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer | Q36868502 | ||
| Soluble cadherins as cancer biomarkers | Q36977717 | ||
| Long-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers | Q37045624 | ||
| Evaluation of Helicobacter pylori Immunoglobulin G (IgG), IgA, and IgM serologic testing compared to stool antigen testing | Q37301857 | ||
| Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer | Q37580278 | ||
| Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments | Q38015669 | ||
| Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer | Q38575232 | ||
| How Helicobacter pylori senses, targets and interacts with the gastric epithelium | Q38697118 | ||
| Evaluation of specific biochemical indicators of Helicobacter pylori-associated gastric cancer in Egypt | Q38877239 | ||
| Comparative Evaluation of RUT, PCR and ELISA Tests for Detection of Infection with Cytotoxigenic H. pylori | Q39099897 | ||
| Exploiting the Gastric Epithelial Barrier: Helicobacter pylori's Attack on Tight and Adherens Junctions | Q39104038 | ||
| The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases | Q39448761 | ||
| Serodiagnosis of Helicobacter pylori infection in childhood. | Q40203281 | ||
| Diagnosis of Helicobacter pylori infection by invasive and noninvasive tests | Q41824675 | ||
| Host pathogen interactions in Helicobacter pylori related gastric cancer | Q42317764 | ||
| Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing | Q42691689 | ||
| Non-Invasive Diagnosis of Helicobacter pylori: Evaluation of Two Enzyme Immunoassays, Testing Serum IgG and IgA Response in the Anand District of Central Gujarat,India | Q42783523 | ||
| Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy. | Q43178500 | ||
| Blood serum levels of E-cadherin in patients with colorectal cancer | Q47112850 | ||
| Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer | Q47124055 | ||
| E-cadherin: Its dysregulation in carcinogenesis and clinical implications. | Q49570064 | ||
| Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. | Q51026487 | ||
| Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors? | Q53078952 | ||
| Expression of the E-cadherin/β-catenin/tcf-4 pathway in gastric diseases with relation to Helicobacter pylori infection: clinical and pathological implications. | Q53242128 | ||
| Accuracy of diagnostic tests for Helicobacter pylori in patients with peptic ulcer bleeding. | Q53384583 | ||
| Preoperative serum CEA and CA19-9 in gastric cancer--a single tertiary hospital study of 1,075 cases. | Q53553183 | ||
| An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4. | Q53607038 | ||
| Non-invasive diagnostic tests for Helicobacter pylori infection. | Q54255472 | ||
| Five common tumor biomarkers and CEA for diagnosing early gastric cancer: A protocol for a network meta-analysis of diagnostic test accuracy. | Q55033589 | ||
| Diagnosis of Helicobacter pylori Using Invasive and Noninvasive Approaches. | Q55301374 | ||
| Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer | Q73521245 | ||
| Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin | Q81914328 | ||
| A forgotten cause of false negative rapid urease test: formalin contamination of the sample | Q84709316 | ||
| P433 | issue | 3 | |
| P921 | main subject | Helicobacter pylori | Q180556 |
| gastric ulcer | Q4003020 | ||
| P304 | page(s) | 269-277 | |
| P577 | publication date | 2019-10-01 | |
| P1433 | published in | Reports of biochemistry & molecular biology | Q27726936 |
| P1476 | title | E-Cadherin Protein as a Potential Marker for Gastric Cancer and Its Association with Helicobacter Pylori- Induced Gastritis and Gastric Ulcer | |
| P478 | volume | 8 |
Search more.